Related content

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis

By                

Oncology Letters, Vol. 7, Iss. 2, 2014-01 ,pp. : 534-540

Spandidos Publications

Access to resources Recommend Favorite

Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction

By Goto Hironobu   Tokunaga Masanori   Sugisawa Norihiko   Tanizawa Yutaka   Bando Etsuro   Kawamura Taiichi   Niihara Masahiro   Tsubosa Yasuhiro   Terashima Masanori  

Gastric Cancer, Vol. 16, Iss. 4, 2013-10 ,pp. : 590-595

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

By Malik Imtiaz   Bernal Pedro   Byrd Janet  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 833-838

Informa Healthcare

Access to resources Recommend Favorite

Fiber intake and risk of adenocarcinomas of the esophagus and stomach

By Wu Anna   Tseng Chiu-Chen   Hankin Jean   Bernstein Leslie  

Cancer Causes and Control, Vol. 18, Iss. 7, 2007-09 ,pp. : 713-722

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy for Nonmetastatic Esophago-Gastric Adenocarcinomas: A Systematic Review and Meta-Analysis

By Zhang Chun-Dong   Zeng Yong-Ji   Li Hong-Wu   Zhao Zhe-Ming   Zhang Jia-Kui   Dai Dong-Qiu  

Cancer Investigation, Vol. 31, Iss. 6, 2013-07 ,pp. : 421-431

Informa Healthcare

Access to resources Recommend Favorite